Carson, W E <br/><br/>
The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Aug 1994 
 - 7553-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.91.16.7553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD<br/>Antigens, Differentiation, T-Lymphocyte<br/>Apoptosis--drug effects<br/>Base Sequence<br/>CD56 Antigen<br/>Cell Survival<br/>Cells, Cultured<br/>Hematopoietic Cell Growth Factors--pharmacology<br/>Humans<br/>Killer Cells, Natural--drug effects<br/>Molecular Sequence Data<br/>Proto-Oncogene Proteins--biosynthesis<br/>Proto-Oncogene Proteins c-bcl-2<br/>Proto-Oncogene Proteins c-kit<br/>Receptor Protein-Tyrosine Kinases--metabolism<br/>Receptors, Colony-Stimulating Factor--metabolism<br/>Stem Cell Factor<br/>Up-Regulation